“Monoclonal antibodies are our core competence,” said Yoshinori Yamashita, Head of R&D Division & Business Development. Chiome was established in 2005 to commercialize ADLib, an innovative ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Human gene patents that included antibody claims with experimental antibody ... reaching about one-third of all human gene patents in 2005. Figure 2: Annual change in the number of each category ...

Robert F. Kennedy Jr., one of President-elect Donald Trump’s advisers on health, is taking aim at the agency’s oversight on ...

The CDC study provides the largest window to date into how the bird virus first detected in March in dairy cows may be ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The investigational monoclonal antibody clesrovimab protected against respiratory syncytial virus (RSV) disease and ...

One study showed it can wipe out anywhere from 11 to 73 percent of the antibodies that protect against strains of various ...

Antivenom (often spelled “antivenin”) is an antibody product that can disable a particular venom’s toxins. If injected quickly after a bite or sting, the antibodies in antivenom neutralize the venom, ...

The team of pioneering Japanese researchers, led by Katsu Takahashi, is making remarkable strides toward developing a drug ...

Current cancer vaccines use antibodies as targeting systems to find these dendritic cells. Antibodies are Y-shaped proteins that can lock onto specific structures on cell surfaces, like a key fitting ...

With the first category -- microvascular inflammation or injury without evidence of a donor-specific antibody-mediated response -- graft loss was 2.1-fold more likely (95% CI 1.5-3.1) than among ...

Researchers at Fred Hutchinson Cancer Center, led by Dr. Julie McElrath, Director of the Vaccine and Infectious Disease Division, have found a new way to train our immune system to make antibodies ...